483
Takeda Pharmaceuticals USA, Inc.Takeda Pharmaceuticals USA, Inc. – FDA 483
Record Details
An FDA inspection of Takeda Pharmaceuticals USA, Inc. in Deerfield, IL, identified a significant issue regarding the conduct of clinical investigations. The firm failed to ensure that studies were conducted in accordance with their general investigational plans and protocols. Specifically, problems were noted with subject randomization and stratification in two clinical studies, leading to a substantial number of mis-stratified or ineligible subjects.
- Product type
- drugs
View Company Profile
ID · da485ef1-26ca-4a32-9311-d2bcb54158ac
Other documents for Takeda Pharmaceuticals USA, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.